AJP - Cell Physiology, Vol 256, Issue 1 C75-C80, Copyright © 1989 by American Physiological Society

ARTICLES

Rates of synthesis and degradation of Na+-K+-ATPase during chronic ouabain treatment

B. M. Rayson
Department of Physiology, Cornell University Medical College, New York.

Chronic inhibition of Na+-K+-ATPase activity in outer medullary kidney tubules has previously been demonstrated to elicit a 60% increase in activity, measured under maximal velocity (Vmax) conditions (J. Biol. Chem. 260: 12740-12743, 1985). To investigate the cellular mechanism of this response, we measured the rates of Na+-K+-ATPase synthesis and degradation over its full time course. A transient increase in the rate of synthesis occurred after 12 h of ouabain treatment. After 24-h treatment, the rate of synthesis returned to a level not different from control levels. The relative degradation rate after 24-h treatment, however, was markedly lower in ouabain-treated cells than in control cells. Thus the augmentation of the number of Na+-K+-ATPase sites, elicited by the transient increase in synthesis described, was maintained under steady-state conditions by a reduction in apparent degradation rate constant.

This article has been cited by other articles:

				X. Zhou, W. Yin, S. Q. Doi, S. W. Robinson, K. Takeyasu, and X. Fan Stimulation of Na,K-ATPase by low potassium requires reactive oxygen species Am J Physiol Cell Physiol, August 1, 2003; 285(2): C319 - C326. [Abstract] [Full Text] [PDF]

				S. A. Rajasekaran, L. G. Palmer, S. Y. Moon, A. Peralta Soler, G. L. Apodaca, J. F. Harper, Y. Zheng, and A. K. Rajasekaran Na,K-ATPase Activity Is Required for Formation of Tight Junctions, Desmosomes, and Induction of Polarity in Epithelial Cells Mol. Biol. Cell, December 1, 2001; 12(12): 3717 - 3732. [Abstract] [Full Text] [PDF]

				G. DESCHENES, S. GONIN, E. ZOLTY, L. CHEVAL, M. ROUSSELOT, P.-Y. MARTIN, J.-M. VERBAVATZ, E. FERAILLE, and A. DOUCET Increased Synthesis and AVP Unresponsiveness of Na,K-ATPase in Collecting Duct from Nephrotic Rats J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2241 - 2252. [Abstract] [Full Text] [PDF]

				J. M. Capasso, C. J. Rivard, and T. Berl Long-term adaptation of renal cells to hypertonicity: role of MAP kinases and Na-K-ATPase Am J Physiol Renal Physiol, May 1, 2001; 280(5): F768 - F776. [Abstract] [Full Text] [PDF]

				P. Ferrari, M. Ferrandi, G. Tripodi, L. Torielli, G. Padoani, E. Minotti, P. Melloni, and G. Bianchi PST 2238: A New Antihypertensive Compound that Modulates Na,K-ATPase in Genetic Hypertension J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1074 - 1083. [Abstract] [Full Text]

				P. Ferrari, L. Torielli, M. Ferrandi, G. Padoani, L. Duzzi, M. Florio, F. Conti, P. Melloni, L. Vesci, N. Corsico, et al. PST2238: A New Antihypertensive Compound That Antagonizes the Long-Term Pressor Effect of Ouabain J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 83 - 94. [Abstract] [Full Text]

				M. Ferrandi, G. Tripodi, S. Salardi, M. Florio, R. Modica, P. Barassi, P. Parenti, A. Shainskaya, S. Karlish, G. Bianchi, et al. Renal Na,K-ATPase in Genetic Hypertension Hypertension, December 1, 1996; 28(6): 1018 - 1025. [Abstract] [Full Text]